STOCK TITAN

Horizon Quantum Holdings Ltd. (HQ) Form 4 Filings

HQ NASDAQ

Here are the Form 4 insider transactions from Horizon Quantum Holdings Ltd. (HQ) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow HQ and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HQ filings page.

Rhea-AI Summary

Horizon Quantum Holdings Ltd. Chief Product Officer Qian Yi Amanda Chew had 1,116 restricted stock units vest on November 17, 2026; each RSU represents a contingent right to receive one Class A ordinary share for no consideration. She acquired 1,116 Class A ordinary shares and disposed of 268 shares to the company in a cash settlement at $9.85 per share, the last reported sales price that day. The RSUs vest in equal installments on successive quarterly anniversaries, subject to continued employment.

Rhea-AI Summary

Horizon Quantum Holdings Ltd. director and 10% owner Harry L. You reported that dMY Squared Sponsor, LLC distributed shares and warrants to its members for no consideration on November 3, 2026. You received 1,163,484 Class A Ordinary Shares and 1,442,330 warrants, which he now owns directly. The share transfer changed only the form of his beneficial ownership; his reported direct share position afterward was 1,212,698 shares. The warrants have an exercise price of $11.50 and expire March 19, 2031.

Rhea-AI Summary

Horizon Quantum Holdings Ltd. granted 601,932 stock options to its CLO and CCO, Catherine Michele Fitzsimons, on June 11, 2026. Each option has a $10.78 exercise price and is exercisable for one Class A Ordinary Share. The options vest in 16 approximately equal quarterly installments over four years beginning August 11, 2026, subject to continued employment, and expire June 11, 2036. The footnote states that 37,620 options were fully vested and exercisable as of June 11, 2026.

Rhea-AI Summary

Horizon Quantum Holdings Ltd. (symbol: HQ) is the issuer of record for a Form 4 filing submitted to the SEC. Chew Qian Yi Amanda reported acquisition or exercise transactions in this Form 4 filing.

Horizon Quantum Holdings Ltd. (HQ) reported that Chief Product Officer Chew Qian Yi Amanda received a grant of 17,857 Restricted Stock Units (RSUs) on August 17, 2026. Each RSU represents a contingent right to receive one Class A ordinary share of the company for no consideration upon vesting.

The 17,857 RSUs vest in sixteen approximately equal installments on successive quarterly anniversaries of the August 17, 2026 grant date, subject to Ms. Chew’s continued employment through each vesting date. Following this grant, she holds 17,857 RSUs directly.

Rhea-AI Summary

Horizon Quantum Holdings Ltd. (HQ) reported that officer Catherine Michele Fitzsimons had restricted stock unit (RSU) activity and a related share disposition. On June 12, 2026, she was granted 34,372 RSUs, each for one Class A ordinary share, vesting in approximately equal quarterly installments subject to continued employment. On September 12, 2026, 2,148 RSUs vested and were settled into the same number of Class A ordinary shares, and 1,122 underlying shares were returned to the company in a disposition reflecting cash settlement of a portion of the vested RSUs at a reference price of $15.22 per share. No Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

Horizon Quantum Holdings Ltd. (HQ) reported equity compensation activity for its Chief Financial Officer, Greg Gould. On June 12, 2026, Gould received a grant of 54,995 RSUs, each representing a contingent right to receive one Class A Ordinary Share for no consideration, vesting in sixteen approximately equal quarterly installments, subject to continued employment.

On September 12, 2026, 3,437 of Gould’s RSUs vested and were exercised into 3,437 Class A Ordinary Shares. Of these, 1,272 shares were disposed to Horizon Quantum Holdings Ltd. in a cash settlement of a portion of the vested RSUs at $15.22 per share, reflecting the last reported sales price on September 11, 2026. No Rule 10b5-1 trading plan is indicated for these transactions.

Rhea-AI Summary

Horizon Quantum Holdings Ltd. (HQ) reported insider equity activity by Chief Science Officer Dr. Tan Si-Hui and her spouse. On September 12, 2026, 5,728 RSUs vested for Dr. Tan, converting into an equal number of Class A Ordinary Shares, followed by a disposition of 2,991 shares to the company for cash settlement at $15.22 per share. Earlier, on June 12, 2026, Dr. Tan received a grant of 91,659 RSUs that vest in sixteen approximately equal quarterly installments. Dr. Tan’s spouse received a grant of 3,600 RSUs on August 20, 2026, vesting over time, and holds 55,000 stock options with a $2.88 exercise price, exercisable in aggregate for 133,924 Class A Ordinary Shares, a portion of which is already vested and the remainder vesting in quarterly installments.

Rhea-AI Summary

Horizon Quantum Holdings Ltd. (HQ) reported that Chief Executive Officer and director Joseph Francis Fitzsimons had 14,321 RSUs vest on September 12, 2026, which were converted into the same number of Class A ordinary shares. A portion of these vested units, 3,438 shares, was settled in cash through a disposition to the company at $15.22 per share, based on the last reported sales price on September 11, 2026. Separately, on June 12, 2026, he received a grant of 229,148 unvested RSUs that vest in sixteen approximately equal quarterly installments, subject to continued employment. No Rule 10b5-1 trading plan is reported for these transactions.

Rhea-AI Summary

Horizon Quantum Holdings Ltd. reported an indirect insider purchase linked to its business combination closing. On March 19, 2026, Penchant Family Holdings LLC acquired 84,602 Class A Ordinary Shares at $11.82 per share, for an aggregate price of approximately $1,000,000. The shares are held by Penchant Family Holdings LLC, which is controlled by Penchant Holdings, Inc., where director Danielle Lambert serves as President, so her interest is through this affiliated entity rather than direct personal ownership.

Rhea-AI Summary

Tan Si-Hui reported acquisition or exercise transactions in this Form 4 filing.

Horizon Quantum Holdings Ltd. reported that Chief Science Officer Dr. Tan Si-Hui received a grant of 500,000 stock options on March 19, 2026. Each option is exercisable at $0.15 per Class A Ordinary Share and is exercisable for 2.43499 Class A Ordinary Shares, covering 1,217,494 underlying Class A Ordinary Shares.

These fully vested options were not a new cash purchase but were issued in exchange for Dr. Tan’s 500,000 Legacy Horizon stock options as part of the closing of the Business Combination under the Business Combination Agreement. Following this exchange, Dr. Tan holds 500,000 Company stock options directly.

Rhea-AI Summary

Horizon Quantum Holdings Ltd. reported that Chief Financial Officer Greg Gould received a grant of 285,300 stock options as part of the company’s recent business combination. Each option is exercisable into 2.43499 Class A Ordinary Shares, covering 694,702 shares in total, at an exercise price of $5.13 per share, and expires on August 15, 2035.

The award reflects an exchange of Mr. Gould’s prior Legacy Horizon options for equivalent company options at the March 19, 2026 business combination closing. The options vest quarterly in 16 equal installments beginning August 15, 2025; as of March 24, 2026, 35,662 options are vested and exercisable, with 249,638 scheduled to vest over time, contingent on continued employment.

Rhea-AI Summary

Horizon Quantum Holdings Ltd. reported that Chief Executive Officer and director Dr. Joseph Francis Fitzsimons acquired 19,744,585 Class B Ordinary Shares on March 19, 2026 at a stated price of $0.00 per share as a grant/award acquisition.

The footnotes explain that this occurred when the company completed its business combination under the Business Combination Agreement dated September 9, 2025. Dr. Fitzsimons exchanged 8,108,696 ordinary shares of Horizon Quantum Computing Pte. Ltd. for the 19,744,585 Class B Ordinary Shares.

Each Class B Ordinary Share is convertible at any time into one Class A Ordinary Share. Following this transaction, Dr. Fitzsimons directly holds 19,744,585 Class B Ordinary Shares, reflecting his continuing equity stake after the business combination.

Rhea-AI Summary

Horizon Quantum Holdings Ltd. reported that dMY Squared Sponsor, LLC, an entity associated with director and 10% owner Harry L. You, acquired indirect equity interests in connection with the closing of its business combination with Horizon Quantum Computing Pte. Ltd. and dMY Squared Technology Group, Inc.

The Sponsor received 1,163,484 Class A ordinary shares as a grant in exchange for 1,163,484 shares of DMY Class A common stock, and 2,884,660 warrants to purchase Class A ordinary shares at an exercise price of $11.50 per share, both at a transaction price of $0.00 per security. On the business combination effective date, DMY’s Class A common stock closed at $13.50 and its warrants at $2.69.

After these transactions, Mr. You is reported with 1,163,484 Class A ordinary shares and 2,884,660 warrants held indirectly through the Sponsor and 49,214 Class A ordinary shares held directly, while each reporting person disclaims beneficial ownership except to the extent of pecuniary interest.